Drug resistance and response
Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance. The emergence of multidrug resistance, including resistance to artemisinin and partner drugs, is a public health concern threatening the sustainability of the ongoing global effort to reduce the burden of malaria. The Global Technical Strategy for Malaria 2016–2030 calls on countries and global malaria partners to monitor the efficacy of antimalarial medicines so that the most appropriate treatments can be selected for national policies.
Questions & answers
Malaria Threats Maps
Call for experts
The WHO Global Malaria Programme is currently issuing a call for experts to serve as members of the Guidelines Development Group.